LitAlert ~~

    • Management of BRCA tumour testing in an integrated Molecular Tumour Board multidisciplinary model.
    • Azzollini J, Vingiani A, Agnelli L, Tamborini E, Perrone F, Conca E, Capone I, Busico A, Peissel B, Rosina E, Ducceschi M, Mantiero M, Lopez S, Raspagliesi F, Niger M, Duca M, Damian S, Proto C, De Braud F, Pruneri G, Manoukian S.
    • Front Oncol. 2022 Mar 17;12:857515. doi: 10.3389/fonc.2022.857515.
    • Lynparza Survival Benefit, FDA Approval in Early-Stage Breast Cancer Could Broaden Genetic Testing.
    • Hopkins C.
    • Precision Oncology News. Biomarkers. BRCA. 2022 Mar 17.
    • News

    Clinical Trials: Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA). (

    • Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body.
    • Werner-Lin A, Shepherd RF, Young JL, Wilsnack C, Merrill SL, Greene MH, Khincha PP.
    • Soc Sci Med. 2022 Mar 17. doi: 10.1016/j.socscimed.2022.114905. Epub ahead of print.
    • A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
    • Mortlock S, Corona RI, Kho PF, Pharoah P, Seo JH, Freedman ML, Gayther SA, Siedhoff MT, Rogers PAW, Leuchter R, Walsh CS, Cass I, Karlan BY, Rimel BJ, Ovarian Cancer Association Consortium, International Endometriosis Genetics Consortium, Montgomery GW, Lawrenson K, Kar SP.
    • Cell Rep Med. 2022 Mar 15;3(3):100542. doi: 10.1016/j.xcrm.2022.100542.

    Research news: Ovarian Cancer Subtypes, Endometriosis Show Genetic Overlap in Study. (GenomeWeb)